Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

Peering Into Horizon Therapeutics’s Recent Short Interest

By Benzinga Insights
October 5, 4:15 PM
Horizon Therapeutics’s (NYSE:HZNP) short percent of float has fallen 25.18% since its last report. The company recently reported…

HZNP

Read More
1 minute read
  • M&A
  • News

Horizon Therapeutics Announced Acquisition By Amgen Approved By The High Court Of Ireland

By Charles Gross
October 5, 7:39 AM
-8-K As previously disclosed, on December 11, 2022, Horizon Therapeutics plc (“Horizon”), Amgen Inc. (“Amgen”) and Pillartree Limited, a whollyowned subsidiary of Amgen (“Acquirer

AMGN

Read More
1 minute read
  • Dividends
  • Earnings
  • News

Here’s How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today

By Benzinga Insights
October 4, 12:30 PM
Horizon Therapeutics (NASDAQ:HZNP) has outperformed the market over the past 5 years by 36.06% on an annualized basis…

HZNP

Read More
2 minute read
  • Biotech
  • Events
  • General
  • News

Horizon Therapeutics Plc Announces New UPLIZNA Data In Neuromyelitis Optica Spectrum Disorder To Be presented At ECTRIMS 2023

By Benzinga Newsdesk
October 2, 8:14 AM
-- Presentations will feature data from the pivotal Phase 3 study of UPLIZNA, including new biomarker analyses --Horizon Therapeutics plc (NASDAQ:HZNP) today announced that new UPLIZNA analyses will be presented at the

HZNP

Read More
4 minute read
  • Biotech
  • General
  • News

Horizon Therapeutics Plc Announces New Analysis Highlights Importance Of Adhering To Uninterrupted Full Course Of Treatment With TEPEZZA To Support Thyroid Eye Disease Patient Outcomes

By Benzinga Newsdesk
September 29, 10:03 AM
-- Additional data presented at ATA 2023 include a subgroup analysis from the TEPEZZA Phase 4 clinical trial and insights on the impact of TED on quality of life (QOL) --Horizon Therapeutics plc (NASDAQ:HZNP) today

HZNP

Read More
5 minute read
  • Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights
September 28, 1:35 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

ALGN

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

How Is The Market Feeling About Horizon Therapeutics?

By Benzinga Insights
September 18, 10:15 AM
Horizon Therapeutics’s (NYSE:HZNP) short percent of float has risen 20.52% since its last report. The company recently reported…

HZNP

Read More
2 minute read
  • Analyst Ratings
  • Dividends
  • Long Ideas
  • Markets
  • News
  • Pre-Market Outlook
  • Price Target
  • Trading Ideas

These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street’s Most Accurate Analysts

By Lisa Levin
September 13, 7:35 AM
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

AMGN

Read More
1 minute read
  • Dividends
  • Earnings
  • News

$1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today

By Benzinga Insights
September 12, 4:30 PM
Horizon Therapeutics (NASDAQ:HZNP) has outperformed the market over the past 10 years by 32.84% on an annualized basis…

HZNP

Read More
5 minute read
  • Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights
September 11, 1:35 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

ABT

Posts pagination

1 2 … 14 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service